Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Heart Valve Disease, Postoperative Pain

In brief

This randomized, double-blind, placebo-controlled study aims to evaluate the effect of the serratus posterior superior intercostal plane (SPSIP) block on postoperative pain and opioid consumption in patients undergoing minimally invasive cardiac valve surgery via mini-thoracotomy.

Key facts

Study ID

NCT07588230

Run by

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

People needed

90

Starts

2026-05-16

Expected to finish

2026-10-26

Last updated by the study team

2026-05-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients aged 18-75 years
• ASA physical status I-III
• Scheduled for elective minimally invasive cardiac valve surgery via mini-thoracotomy
• Able to understand and use the Numeric Rating Scale (NRS)
• Provided written informed consent

You may not qualify if…

• Age >75 years
• Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine)
• Coagulopathy or ongoing anticoagulant therapy that cannot be discontinued
• Infection at the planned block site
• Chronic opioid use or chronic pain conditions
• Severe pulmonary disease affecting respiratory assessment
• Neurological or psychiatric disorders interfering with pain assessment
• Emergency surgery
• Pregnancy or breastfeeding
• Refusal to participate

Where it is running

• Fatma Acil — Diyarbakır, Outside of the US, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.